Compare
DSwiss Inc vs Bonk, Inc. vs cbdMD, Inc. vs Axil Brands, Inc.
| Latest fiscal year | DSwiss Inc DQWS | Bonk, Inc. BNKK | cbdMD, Inc. YCBD | Axil Brands, Inc. AXIL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 | 2026-05-31 |
| Revenue | $2.92M | $2.12M | $19.19M | $30.85M |
| Revenue growth (YoY) | -6.2% | +201.6% | -1.5% | +17.5% |
| Gross margin | 19.3% | 58.5% | 62.4% | 69.3% |
| Operating margin | 0.0% | n/a | -11.3% | 9.7% |
| Net margin | -2.6% | n/m | -10.6% | 8.8% |
| Net income | -$76.9K | -$68.19M | -$2.04M | $2.70M |
| EPS (Diluted) | $0.00 | -$17.02 | -$1.09 | $0.33 |
| Operating cash flow | -$94.3K | -$25.28M | -$1.45M | -$9.6K |
| Free cash flow | -$135.3K | n/a | -$1.64M | -$89.0K |
| Cash & equivalents | $285.0K | n/a | $2.26M | $4.46M |
| Total assets | $677.1K | $40.97M | $10.42M | $17.96M |
| Total liabilities | $686.5K | $5.98M | $3.19M | $4.81M |
| Shareholders' equity | -$9.3K | $35.00M | $7.23M | $13.14M |
| Return on year-end equity | n/a | -194.8% | -28.2% | 20.5% |
| Shares outstanding | 206.90M | 7.75M | 8.92M | 6.82M |
Revenue, most recent five fiscal years
| Fiscal year | DSwiss Inc | Bonk, Inc. | cbdMD, Inc. | Axil Brands, Inc. |
|---|---|---|---|---|
| Latest | $2.92M Ended 2025-12-31 | $2.12M Ended 2025-12-31 | $19.19M Ended 2025-09-30 | $30.85M Ended 2026-05-31 |
| 1 year earlier | $3.11M Ended 2024-12-31 | $702.0K Ended 2024-12-31 | $19.48M Ended 2024-09-30 | $26.26M Ended 2025-05-31 |
| 2 years earlier | $1.47M Ended 2023-12-31 | $202.7K Ended 2023-12-31 | $24.16M Ended 2023-09-30 | $27.50M Ended 2024-05-31 |
| 3 years earlier | $1.85M Ended 2022-12-31 | $120.6K Ended 2022-12-31 | $35.40M Ended 2022-09-30 | $23.52M Ended 2023-05-31 |
| 4 years earlier | $1.96M Ended 2021-12-31 | $2.88M Ended 2021-12-31 | $44.48M Ended 2021-09-30 | $2.34M Ended 2022-05-31 |